222 related articles for article (PubMed ID: 28801271)
1. Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
Negi N; Singh R; Sharma A; Das BK; Vajpayee M
Microb Pathog; 2017 Oct; 111():331-337. PubMed ID: 28801271
[TBL] [Abstract][Full Text] [Related]
2. Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
Papasavvas E; Pistilli M; Reynolds G; Bucki R; Azzoni L; Chehimi J; Janmey PA; DiNubile MJ; Ondercin J; Kostman JR; Mounzer KC; Montaner LJ
AIDS; 2009 Jan; 23(3):369-75. PubMed ID: 19114856
[TBL] [Abstract][Full Text] [Related]
3. Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.
Monnig MA; Kahler CW; Cioe PA; Tucker L; Monti PM; Mayer KH; Ramratnam B
AIDS Care; 2016 Nov; 28(11):1434-40. PubMed ID: 27242060
[TBL] [Abstract][Full Text] [Related]
4. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
5. Markers of microbial translocation predict hypertension in HIV-infected individuals.
Manner IW; Baekken M; Kvale D; Oektedalen O; Pedersen M; Nielsen SD; Nowak P; Os I; Trøseid M
HIV Med; 2013 Jul; 14(6):354-61. PubMed ID: 23332095
[TBL] [Abstract][Full Text] [Related]
6. Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers.
Romero-Sánchez M; González-Serna A; Pacheco YM; Ferrando-Martínez S; Machmach K; García-García M; Alvarez-Ríos AI; Vidal F; Leal M; Ruiz-Mateos E
J Infect; 2012 Nov; 65(5):431-8. PubMed ID: 22728172
[TBL] [Abstract][Full Text] [Related]
7. Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
Toossi Z; Funderburg NT; Sirdeshmuk S; Whalen CC; Nanteza MW; Johnson DF; Mayanja-Kizza H; Hirsch CS
J Infect Dis; 2013 Jun; 207(12):1841-9. PubMed ID: 23479321
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
[TBL] [Abstract][Full Text] [Related]
9. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy.
Wallet MA; Rodriguez CA; Yin L; Saporta S; Chinratanapisit S; Hou W; Sleasman JW; Goodenow MM
AIDS; 2010 Jun; 24(9):1281-90. PubMed ID: 20559035
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler NG; Wand H; Roque A; Law M; Nason MC; Nixon DE; Pedersen C; Ruxrungtham K; Lewin SR; Emery S; Neaton JD; Brenchley JM; Deeks SG; Sereti I; Douek DC;
J Infect Dis; 2011 Mar; 203(6):780-90. PubMed ID: 21252259
[TBL] [Abstract][Full Text] [Related]
11. The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation.
Chevalier MF; Petitjean G; Dunyach-Rémy C; Didier C; Girard PM; Manea ME; Campa P; Meyer L; Rouzioux C; Lavigne JP; Barré-Sinoussi F; Scott-Algara D; Weiss L
PLoS Pathog; 2013; 9(6):e1003453. PubMed ID: 23818854
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection.
Kelesidis T; Kendall MA; Yang OO; Hodis HN; Currier JS
J Infect Dis; 2012 Nov; 206(10):1558-67. PubMed ID: 23066162
[TBL] [Abstract][Full Text] [Related]
13. Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden.
Abdurahman S; Barqasho B; Nowak P; Cuong do D; Amogné W; Larsson M; Lindquist L; Marrone G; Sönnerborg A
J Int AIDS Soc; 2014; 17(1):18841. PubMed ID: 24461466
[TBL] [Abstract][Full Text] [Related]
14. Role of microbial translocation in soluble CD14 up-regulation in HIV-, but not in HCV-, infected chimpanzees.
Verstrepen BE; Nieuwenhuis IG; Mooij P; Verschoor EJ; Fagrouch ZC; Kondova I; Boonstra A; Koopman G
J Gen Virol; 2016 Oct; 97(10):2599-2607. PubMed ID: 27534537
[TBL] [Abstract][Full Text] [Related]
15. Comparative Proliferation Capacity of Gag-C-Specific Naive and Memory CD4+ and CD8+ T Lymphocytes in Rapid, Viremic Slow, and Slow Progressors During Human Immunodeficiency Virus Infection.
Negi N; Mojumdar K; Singh R; Sharma A; Das BK; Sreenivas V; Vajpayee M
Viral Immunol; 2018 Sep; 31(7):513-524. PubMed ID: 30156469
[TBL] [Abstract][Full Text] [Related]
16. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
Vesterbacka J; Barqasho B; Häggblom A; Nowak P
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
[TBL] [Abstract][Full Text] [Related]
17. Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.
Nyström J; Stenkvist J; Häggblom A; Weiland O; Nowak P
PLoS One; 2015; 10(3):e0118643. PubMed ID: 25785448
[TBL] [Abstract][Full Text] [Related]
18. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Sandler NG; Koh C; Roque A; Eccleston JL; Siegel RB; Demino M; Kleiner DE; Deeks SG; Liang TJ; Heller T; Douek DC
Gastroenterology; 2011 Oct; 141(4):1220-30, 1230.e1-3. PubMed ID: 21726511
[TBL] [Abstract][Full Text] [Related]
19. Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
Nowroozalizadeh S; Månsson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyö EM; Norrgren H; Holmgren B; Jansson M
J Infect Dis; 2010 Apr; 201(8):1150-4. PubMed ID: 20199244
[TBL] [Abstract][Full Text] [Related]
20. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
